Jingyu Y. Xu
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.
Journal: Leukemia
Published: June 09, 2026
Treatment practice and outcomes in 125 patients with autoimmune hemolytic anemia: a single-center retrospective analysis
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: April 16, 2026
Spatiotemporal Variability Analysis of PM2.5 and O3 Pollution Characteristics in the Fenwei Plain.
Journal: Toxics
Published: March 29, 2026
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States.
Journal: Cancers
Published: October 23, 2025
Late and Durable Minimal Residual Disease Response Predicts Favorable Outcomes in Newly Diagnosed Multiple Myeloma.
Journal: International journal of cancer
Published: September 01, 2025
Development of a Cytogenetic Double-Hit Model for Survival Prediction in Multiple Myeloma.
Journal: Cancers
Published: July 28, 2025
Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 12, 2025
Delayed physical growth and related factors in pediatric patients with transfusion-dependent thalassemia
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 27, 2025
Proteasome Subunit PSMD1 is a Key Therapeutic Target in Multiple Myeloma.
Journal: Blood
Published: March 26, 2025
Proteasome subunit PSMD1 is a key therapeutic target in multiple myeloma.
Journal: Blood
Published: March 26, 2025
The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significancelike behavior predict an exceptionally favorable prognosis in multiple myeloma.
Journal: Haematologica
Published: February 06, 2025
The Monoclonal Gammopathy of Undetermined Significance-Like (MGUS-like) Classifier Stratifies Prognosis in Multiple Myeloma: Results from Real-World Data in Chinese Population.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 22, 2024
Last Updated: 09/26/2026